Silvia Bio is a University of Sheffield spinout, incorporated in 2025, that improves the biomanufacturing of biologic drugs such as vaccines, gene therapies and antibodies. Its platform profiles mammalian cell performance to pinpoint the bottlenecks limiting yield and quality, then corrects them with bespoke small-molecule media additives designed for use in bioreactors. The company has worked with several of the world's ten largest pharmaceutical companies, and its published case study reports a 22% increase in antibody output in CHO cells.
1
Round
1
Industry
3
Tags
Oct 15, 2026
Latest raise
Funding activity · 1 round
Oct 15, 2026
GBP 3M
Seed
Led by Northern Gritstone
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
